Ekso Bionics (EKSO) said late Wednesday that it moved the effective date of its planned 1-for-15 reverse stock split of common shares to June 2 from May 27.
With the reverse stock split, the number of the company's shares will decrease to about 2.4 million from 35.5 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.